K vs TERN · P/E 23, $29.03B cap vs $6.12B cap
Kellanova (K) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
K currently screens at market cap $29.03B and trailing P/E 22.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the K and TERN stock pages for the full models.
Not investment advice.